Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EBV Lymphoproliferation”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Early research (Phase 1)Looking for participantsNCT04664179
What this trial is testing

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

Who this might be right for
EBV-Related Hodgkin LymphomaEBV-Related Lymphoproliferative DisorderEBV Related Non-Hodgkin's Lymphoma
Baylor College of Medicine 52
Not applicableStudy completedNCT03343834
What this trial is testing

Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Epstein-Barr ViraemiaHematologic DiseasesAllogeneic Disease
Assistance Publique - Hôpitaux de Paris 138
Early research (Phase 1)Temporarily pausedNCT06741072
What this trial is testing

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Who this might be right for
Chronic Kidney Disease, Stage 4Chronic Kidney Disease, Stage 5EBV-Related Lymphoproliferative Disorder+2 more
Ohio State University Comprehensive Cancer Center 55
Not applicableStudy completedNCT04189835
What this trial is testing

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Who this might be right for
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more
University of Aarhus 509
Testing effectiveness (Phase 2)Ended earlyNCT05011058
What this trial is testing

An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas

Who this might be right for
Epstein-Barr Virus Associated LymphomaEBV-Positive DLBCL, NOSEBV-Related Non-Hodgkin Lymphoma+4 more
Viracta Therapeutics, Inc. 102
Not applicableLooking for participantsNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 500
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20